Track topics on Twitter Track topics that are important to you
ReNeuron Group PLC's (LON:RENE) Michael Hunt caught up with Proactive London's Andrew Scott following the news this morning that they've appointed a business development director, Nick Adams, to help them build on the licence deals signed with Chinese giant Fosun Pharma.
Hunt also discusses the recent release of their preliminary results covering the 12 months to the end of March 2019.
One of the year's highlights came in February, when they reported positive initial data from the mid-stage study of its retinitis pigmentosa treatment.NEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...